Yonsei Med J.  2016 Jul;57(4):1047-1048. 10.3349/ymj.2016.57.4.1047.

Arbekacin as an Alternative Drug to Teicoplanin for the Treatment of MRSA Infection

• Hwang JH
• Lee JH
• Kim JS
• Hwang JH
• Lee CS

• KMID: 2374143
• DOI: http://doi.org/10.3349/ymj.2016.57.4.1047

Abstract

No abstract available.

Reference

1. Miller CE, Batra R, Cooper BS, Patel AK, Klein J, Otter JA, et al. An association between bacterial genotype combined with a high-vancomycin minimum inhibitory concentration and risk of endocarditis in methicillin-resistant Staphylococcus aureus bloodstream infection. Clin Infect Dis. 2012; 54:591–600.

2. Ida T, Okamoto R, Shimauchi C, Okubo T, Kuga A, Inoue M. Identification of aminoglycoside-modifying enzymes by susceptibility testing: epidemiology of methicillin-resistant Staphylococcus aureus in Japan. J Clin Microbiol. 2001; 39:3115–3121.

3. Watanabe T, Ohashi K, Matsui K, Kubota T. Comparative studies of the bactericidal, morphological and post-antibiotic effects of arbekacin and vancomycin against methicillin-resistant Staphylococcus aureus. J Antimicrob Chemother. 1997; 39:471–476.

4. Hwang JH, Lee JH, Moon MK, Kim JS, Won KS, Lee CS. The usefulness of arbekacin compared to vancomycin. Eur J Clin Microbiol Infect Dis. 2012; 31:1663–1666.

5. Hwang JH, Lee JH, Moon MK, Kim JS, Won KS, Lee CS. The efficacy and safety of arbekacin and vancomycin for the treatment in skin and soft tissue MRSA infection: preliminary study. Infect Chemother. 2013; 45:62–68.

6. Manjunath G, Sarnak MJ, Levey AS. Prediction equations to estimate glomerular filtration rate: an update. Curr Opin Nephrol Hypertens. 2001; 10:785–792.

7. Mumoli N, Cei M, Cosimi A. Drug-related hepatotoxicity. N Engl J Med. 2006; 354:2191–2193.

8. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997; 40:1725.

9. Kim TH, Choo EJ, Lee MS, Kim NJ, Woo JH, Ryu J, et al. Clinical efficacy and safety with arbekacin for methicillin-resistant Staphylococcus aureus (MRSA) infections. Korean J Med. 2003; 65:239–244.

10. Hwang JH, Lee JH, Hwang JH, Chung KM, Lee EJ, Yoon YJ, et al. Comparison of arbekacin and vancomycin in treatment of chronic suppurative otitis media by methicillin resistant Staphylococcus aureus. J Korean Med Sci. 2015; 30:688–693.